Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Posttransplant lymphoproliferative

Special Precautions Risk of infections, leukopenia, thrombocytopenia, lymphoma, posttransplant lymphoproliferative disease or other malignancies Pregnancy Category C... [Pg.6]

Martin-Gomez MA, Pena M, Cabello M, Burgos D, Gutierrez C, Sola E, Acedo C, Bailen A, Gonzalez-Molina M. Posttransplant lymphoproliferative disease a series of 23 cases. Transplant Proc 2006 38 2448-50. [Pg.627]

NORFLOXACIN CICLOSPORIN t plasma concentrations of cido-sporin, with risk of nephrotoxicity, myelosuppression, neurotoxicity and excessive immunosuppression, with risk of infection and posttransplant lymphoproliferative disease Inhibition of CYP3A4-mediated metabolism of cidosporin these inhibitors vaiy in potency Monitor plasma cidosporin levels to prevent toxicity. Monitor renal function... [Pg.528]

Anderson P, Schroeder T, Hariharan S, First M. Incidence of posttransplant lymphoproliferative disease in OKT-3 treated renal transplant recipients. Clin Transplant 1993 7 582-5. [Pg.2401]

McAlister V, Grant D, Roy A, Yilmaz Z, Ghent C, Wall W. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. Transplant Proc 1993 25(1 Pt 2) 1400-1. [Pg.2401]

Younes BS, McDiarmidSV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 2000 70(l) 94-9. [Pg.3291]

Figure 39-17 In situ hybridization (iSH) for the Epstein-Barr virus (EBV). ISH hybridization for EBV shows numerous positive signals (dark-blue spots) for EBV using the EBER-I probe.The tissue sample was obtained from a solid-organ transplant patient who developed widespread nodal and extranoda masses.The positive reaction for EBV In this assay supports a diagnosis of posttransplant lymphoproliferative disease. (See Color Plate 6.)... Figure 39-17 In situ hybridization (iSH) for the Epstein-Barr virus (EBV). ISH hybridization for EBV shows numerous positive signals (dark-blue spots) for EBV using the EBER-I probe.The tissue sample was obtained from a solid-organ transplant patient who developed widespread nodal and extranoda masses.The positive reaction for EBV In this assay supports a diagnosis of posttransplant lymphoproliferative disease. (See Color Plate 6.)...
Figure 39-17 (Color Plate 6) shows an example of positive EBV in situ hybridization in a case of posttransplant lymphoproliferative disease. Figure 39-17 (Color Plate 6) shows an example of positive EBV in situ hybridization in a case of posttransplant lymphoproliferative disease.
Lones MA, Shintaku IP, Weiss LM, et al. Posttransplant lymphoproliferative disorder in liver allograft biopsies a comparison of three methods for the demonstration of Epstein Barr virus. Hum Pathol. 1997 28 533-539. [Pg.76]

Pitman SD, Huang Q, Zuppan CW, et al. Hodgkin lymphomalike posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically. Am J Surg Pathol. 2006 30 470-476. [Pg.155]

BL, Burkitt lymphoma BLL, Burkitt-like lymphoma cHL, classical Hodgkin lymphoma IL, immunoblastic lymphoma LBL-B, lymphoblastic lymphoma precursor B-cell LBL-T, lymphoblastic lymphoma precursor T-cell LPL, lymphoplasmacytic lymphoma MM, multiple myeloma N, almost always negative PCLBL, primary cutaneous large B-cell lymphoma PEL, primary effusion lymphoma pHL, lymphocyte predominance Hodgkin lymphoma P-PTLD, polymorphic posttransplant lymphoproliferative disorders P-TCL, peripheral T-cell lymphoma PTLD, posttransplant lymphoproliferative disorders. [Pg.160]

Posttransplant lymphoproliferative disease Paraneoplastic pemphigus IgM polyneuropathies Myasthenia gravis Graft versus host disease... [Pg.227]

Evans syndrome, refractory to immunosuppressive therapy Graft vs. host disease, chronic, steroid refractory Pemphigus vulgaris, severe Posttransplant lymphoproliferative disorder... [Pg.333]

Dolcetti, R. (2007) B lymphocytes and Epstein-Barr vims the lesson of posttransplant lymphoproliferative disorders. Autoimmunity Reviews, 7, 96-101. [Pg.196]

Hori T, Oike F, Hata K, Nishikiori M, Ogura Y, Ogawa K, Takada Y, Egawa H, Nguyen JH, Uemoto S. Hashi-moto s encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by posttransplant lymphoproliferative disorder related to Epstein-Barr virus infection. Transpl Infect Dis 2010 12(4) 347-52. [Pg.596]

The posttransplant lymphoproliferative disorders (PTLD) are abnormal proliferations of lymphoid cells typically containing EBV that occurs in the setting of chronic immunosuppression needed for organ transplantation. The lymphoid proliferations have a variety of histologic, immunophenotypic, genotypic, and clinical features. Most are B-ceU lesions, but rarely there may be T-cell proliferations. [Pg.420]

Chen JM, Barr ML, Chadhum A, et al. Management of lymphoproliferative disorders after cardiac transplantation. Ann Thorac Surg 1993 56(3) 527-538. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988 133(1) 173-192. [Pg.427]

Brittinger WD, Walker G, Twittenhoff WD et al (1997) Vascular access for hemodialysis. Pediatr Nephrol 11 87-95 Bunchman TE (1995) Chronic dialysis in the infant less than 1 year of age. Pediatr Nephrol 9 S18-S22 Burney K, Bradley M, Buckley A et al (2006) Posttransplant lymphoproliferative disorder a pictorial review. Austra-las Radiol 50 412-418... [Pg.411]

Dodd GD 3rd, Ledesma-Medina J, Baron RL, Fuhrman CR (1992) Posttransplant lymphoproliferative disorder in-trathoracic manifestations. Radiology 184 65-69... [Pg.171]

Port FK (2003) Organ donation and transplantation trends in the United States, 2001. Am J Transpl 3 [Suppl 4] 7-12 Reyes J, Green M, Bueno J et al (1996) Epstein-Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 28 2768-2769 Starzl TE, Rowe MI, Todo S et al (1989) Transplantation of multiple abdominal viscera. J Am Med Assoc 261 1449-1457... [Pg.243]

See other pages where Posttransplant lymphoproliferative is mentioned: [Pg.850]    [Pg.850]    [Pg.440]    [Pg.16]    [Pg.95]    [Pg.755]    [Pg.3291]    [Pg.698]    [Pg.1475]    [Pg.1475]    [Pg.1634]    [Pg.566]    [Pg.237]    [Pg.420]    [Pg.257]    [Pg.226]   


SEARCH



Lymphoproliferative disease posttransplant

Posttransplant lymphoproliferative disorder

© 2024 chempedia.info